Literature DB >> 3429219

Myopathy during amiodarone treatment: a case report.

F Carella1, E Riva, L Morandi, E Cappiello, A Mangoni.   

Abstract

The case of a 69-year-old woman who developed muscle weakness on chronic amiodarone treatment is reported. Muscle biopsy showed vacuolar alterations and a marked accumulation of amiodarone and of its metabolite desethylamiodarone was found in the muscle sample despite normal blood levels. Amiodarone-induced morphological alterations of the muscle may be related to the actual tissue concentration rather than to the blood level.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3429219     DOI： 10.1007/BF02333668

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN： 0392-0461


  10 in total

1.  High-performance liquid chromatographic measurement of amiodarone and desethylamiodarone in small tissue samples after enzymatic digestion.

Authors:  G C Storey; P C Adams; R W Campbell; D W Holt
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

2.  Frequent neurologic toxicity associated with amiodarone therapy.

Authors:  M E Charness; F Morady; M M Scheinman
Journal:  Neurology       Date:  1984-05       Impact factor: 9.910

3.  Amiodarone neuropathy.

Authors:  A Martinez-Arizala; S M Sobol; G E McCarty; B R Nichols; L Rakita
Journal:  Neurology       Date:  1983-05       Impact factor: 9.910

4.  Amiodarone distribution in human tissues after sudden death during Holter recording.

Authors:  A P Maggioni; A Maggi; A Volpi; V D'Aranno; G Tognoni; P Giani
Journal:  Am J Cardiol       Date:  1983-07       Impact factor: 2.778

5.  Neuromyopathy during chronic amiodarone treatment. A case report.

Authors:  C Meier; B Kauer; U Müller; H P Ludin
Journal:  J Neurol       Date:  1979-01-05       Impact factor: 4.849

6.  Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function.

Authors:  G D Borowski; C D Garofano; L I Rose; S R Spielman; H R Rotmensch; A M Greenspan; L N Horowitz
Journal:  Am J Med       Date:  1985-03       Impact factor: 4.965

7.  Relationships between amiodarone dosage, drug concentrations, and adverse side effects.

Authors:  J J Heger; E N Prystowsky; D P Zipes
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

8.  The induction of pulmonary phospholipidosis and the inhibition of lysosomal phospholipases by amiodarone.

Authors:  M F Heath; F R Costa-Jussà; J M Jacobs; W Jacobson
Journal:  Br J Exp Pathol       Date:  1985-08

9.  Autophagic vacuoles produced in vitro. I. Studies on cultured macrophages exposed to chloroquine.

Authors:  M E Fedorko; J G Hirsch; Z A Cohn
Journal:  J Cell Biol       Date:  1968-08       Impact factor: 10.539

10.  Autophagic vacuoles produced in vitro. II. Studies on the mechanism of formation of autophagic vacuoles produced by chloroquine.

Authors:  M E Fedorko; J G Hirsch; Z A Cohn
Journal:  J Cell Biol       Date:  1968-08       Impact factor: 10.539
  10 in total
  2 in total

Review 1.  [Medically induced myopathia].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

Review 2.  Adverse reactions of Amiodarone.

Authors:  Ruben Ml Colunga Biancatelli; Viviana Congedo; Leonardo Calvosa; Marco Ciacciarelli; Alessandro Polidoro; Luigi Iuliano
Journal:  J Geriatr Cardiol       Date:  2019-07       Impact factor: 3.327
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.